Lv1
60 积分 2023-11-06 加入
Synthetic Approaches to the New Drugs Approved during 2023
8天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
13天前
已完结
Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17β-hydroxysteroid dehydrogenase type 3
2个月前
已完结
Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents
3个月前
已完结
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)
6个月前
已完结
Discovery and In Vivo Anti-inflammatory Activity Evaluation of a Novel Non-peptidyl Non-covalent Cathepsin C Inhibitor
6个月前
已完结
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)
6个月前
已完结
Three-dimensional saturated C(sp3)-rich bioisosteres for benzene
6个月前
已完结
2-Oxabicyclo[2.1.1]hexanes as saturated bioisosteres of the ortho-substituted phenyl ring
6个月前
已完结
N-tert-Butanesulfinyl Imines: Versatile Intermediates for the Asymmetric Synthesis of Amines
6个月前
已完结
皖公网安备34019202002308
